Sabra Healthcare REIT’s (SBRA) Buy Rating Reaffirmed at Truist Financial

Truist Financial reiterated their buy rating on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a research note published on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has a $22.00 price objective on the real estate investment trust’s stock.

A number of other equities research analysts have also recently commented on SBRA. UBS Group set a $19.00 price objective on shares of Sabra Healthcare REIT in a research note on Thursday, June 18th. Citigroup cut shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and decreased their target price for the company from $24.00 to $19.00 in a research note on Monday, June 22nd. Cantor Fitzgerald raised their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Wells Fargo & Company lifted their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, Raymond James Financial assumed coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, June 17th. They issued an “underperform” rating for the company. Five analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $21.45.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $20.03 on Wednesday. The company has a market capitalization of $5.05 billion, a P/E ratio of 31.79, a P/E/G ratio of 1.50 and a beta of 0.65. The business’s 50-day moving average is $19.70 and its two-hundred day moving average is $19.69. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a fifty-two week low of $17.17 and a fifty-two week high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The firm had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s revenue was up 20.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SBRA. Rothschild Investment LLC lifted its stake in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after acquiring an additional 603 shares during the last quarter. Founders Capital Management purchased a new stake in shares of Sabra Healthcare REIT during the third quarter worth approximately $28,000. Finally, Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT in the 4th quarter valued at $29,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.